We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Two Trials Needed to Test Efficacy of Pneumonia Drugs
FDA: Two Trials Needed to Test Efficacy of Pneumonia Drugs
December 8, 2010
Sponsors of treatments for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) should use two noninferiority or superiority trials to demonstrate an effect on all-cause mortality, according to a new draft guidance.